logo
Gov. Healey, state reps introduce proposals to ban broker fees: What to know

Gov. Healey, state reps introduce proposals to ban broker fees: What to know

Yahoo03-04-2025

If you've moved recently, you may know the pain of having to pay a broker fee on top of all your other moving costs.
In Massachusetts, a broker fee is typically about a month's rent that renters are required to pay before moving in. For a one-bedroom apartment in Massachusetts at the median rent of $2,500, broker's fees in addition to other move in costs means a renter is expected to pay nearly $10,000 up front.
But Gov. Maura Healey and some members of the legislature want to end this practice. Both Healey and state Rep. Tackey Chan, D-Quincy, have filed proposals to end broker fees.
A broker fee is a sum of money that brokers charge tenants for their assistance finding an apartment.
They are an upfront, one-time payment that can be as high as 15% of the annual rent. In Massachusetts, they are usually about one month's rent.
Brokers used to connect tenants to landlords by listing units in publications, answering questions and setting up tours. But in the age of Zillow, in most cases, brokers no longer play as large of a role in the apartment search.
Supporters of broker fees say that the fees make sure that brokers are fairly compensated. If the cost is shifted onto the landlords, they say that rents may increase.
However, opponents say that the fees add an undue financial burden onto renters, especially if the renters are doing most of the work to find the apartment themselves.
In late January, Healey included a proposal in an outside section of her annual budget plan to eliminate renter-paid broker fees.
'Broker fees are an unfair cost for renters, and they should not be on the hook to pay for someone they didn't hire,' said Healey in a statement. 'We're proud to be proposing this change that will save renters thousands of dollars – making it possible for more young people, seniors and families to stay in Massachusetts, help businesses attract the best talent, and put more money back in people's pockets for groceries, health care, and other needs.'
Her proposal would require that the fee be paid by whichever party hires the broker, which is usually the landlord.
State representative Chan also filed a bill in the legislature that would do the same. It uses the same language as Healey's proposal.
'Any fee shall only be paid by the party, lessor or tenant who originally engaged and entered into a contract with the licensed broker or salesperson,' reads Bill H.335 and the governor's proposal.
Healey's proposal would have to be approved by the state legislature to go though, as would the bill.
If Massachusetts bans broker fees, they would be following the example of places like New York City.
New York passed a law last December to make landlords responsible for broker fees. It's set to take effect in June.
Many other major U.S. cities don't have tenant paid broker fees.
This article originally appeared on Standard-Times: Will Massachusetts ban broker fees this year? What to know

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial

Yahoo

timean hour ago

  • Yahoo

Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial

PolyPid Ltd. (NASDAQ:PYPD) on Monday announced topline results from its pivotal SHIELD II Phase 3 trial of D-PLEX100 to prevent surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The SHIELD II trial is designed to assess the efficacy and safety of D-PLEX100 administered concomitantly with the standard of care (SoC), which includes prophylactic systemic antibiotics, compared to the SoC alone arm in the prevention of post-abdominal-surgery incisional infection in patients undergoing abdominal colorectal surgeries with large incisions. The trial's primary endpoint is measured by the proportion of subjects with a surgical site infection or mortality for any reason within 30 days post-surgery. FDA Pushes Pause On Axsome Fibromyalgia Drug, New Trial Required Patient safety will be monitored for an additional 30 days. The trial will enroll patients in centers in the United States, Europe, and Israel. D-PLEX100, PolyPid's lead product candidate, is designed to provide local, prolonged, and controlled antibacterial activity directly at the surgical site to prevent SSIs. Following the administration of D-PLEX100 into the surgical site, the PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients, enabling a prolonged and continuous release of the broad-spectrum antibiotic doxycycline, resulting in a high local concentration of the drug for 30 days for the prevention of SSIs, with additional potential to prevent SSIs caused by antibiotic-resistant bacteria at the surgical site. The trial met the primary efficacy endpoint, with a significantly lower proportion of primary endpoint events among patients who received D-PLEX100 plus SoC (n=405; 10.9%), compared to SoC alone (n=393; 18.1%), representing a 38% reduction (p<0.005). SHIELD II included three key secondary endpoints: The first key secondary endpoint was met, with a 58% reduction in deep and superficial SSI rates among patients who received D-PLEX100 plus SoC (3.8%) compared to those who received SoC alone (9.5%) (p<0.005). The second key secondary endpoint showed statistical significance in favor of D-PLEX100 plus SoC over SoC alone (p<0.005). The third key secondary endpoint was met with a 62% reduction of patients with an ASEPSIS1 score >20 in the D-PLEX100 plus SoC arm compared to the SoC alone arm (p<0.05). The ASEPSIS score is a clinical tool used to assess surgical wound infections objectively. The independent Data Safety Monitoring Board raised no safety concerns in SHIELD II. The company expects to submit a New Drug Application to the U.S. Food and Drug Administration in early 2026, with a Marketing Authorization Application in the E.U. to follow shortly thereafter. Price Action: PYPD stock is trading higher by 12% to $3.66 at last check Monday. Read Next:Photo by ittawit21 via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.

Schumer: National Guard deployment to LA ‘unnecessary, inflammatory, and provocative'
Schumer: National Guard deployment to LA ‘unnecessary, inflammatory, and provocative'

The Hill

timean hour ago

  • The Hill

Schumer: National Guard deployment to LA ‘unnecessary, inflammatory, and provocative'

Senate Minority Leader Chuck Schumer (D-N.Y.) on Monday panned President Trump's decision to deploy the National Guard in response to protests in Los Angeles over the administration carrying out its deportation plans. Schumer argued that Trump's activation of the National Guard was a 'diversion' from his ongoing spat with Elon Musk and what Democrats say is an 'ugly' tax cut package moving through the Senate. 'His order to deploy the National Guard in California is unnecessary, inflammatory, and provocative,' Schumer said. 'Trump should immediately revoke his command to use the National Guard, and leave the law enforcement to the governor and the mayor, who are more than capable of handling the situation.' 'Americans do not need or deserve this unnecessary and provocative chaos,' he added. The comments came after 300 National Guard troops arrived in Los Angeles on Sunday amid three days of protests in the nation's second-largest city. Other Democrats, including California Gov. Gavin Newsom (D) and Los Angeles Mayor Karen Bass (D) have also criticized the move, which Trump undertook over Newsom's objections. Trump has shown no signs of backing down though, as roughly 500 Marines were being 'prepared to deploy' to the city. 'Violent, insurrectionist mobs are swarming and attacking our Federal Agents to try and stop our deportation operations,' Trump said on Sunday, adding that he has directed relevant Cabinet officials 'to take all such action necessary to liberate Los Angeles from the Migrant Invasion, and put an end to these Migrant riots.'

Republican rep indicates he will be 'a no' on Trump-backed rescissions measure if AIDS relief cut
Republican rep indicates he will be 'a no' on Trump-backed rescissions measure if AIDS relief cut

Yahoo

timean hour ago

  • Yahoo

Republican rep indicates he will be 'a no' on Trump-backed rescissions measure if AIDS relief cut

As the Trump administration and congressional Republicans eye passage of a rescission proposal, Rep. Don Bacon, a Nebraska Republican who doesn't shy away from bucking President Donald Trump, has indicated that he won't support it if it guts an AIDS relief program. The president's proposed clawbacks include millions of dollars pertaining to global health programs. "I told them I'm a no," the congressman said of the measure, according to the New York Times. "I just want to make sure we're funding the medicine. We want to prevent AIDS, it's a noble program, it's George Bush's legacy. I put the marker out there; we'll see." In a post on X last week, Bacon described "The President's Emergency Plan for AIDS Relief (PEPFAR)" as "a noble program that America can be proud of funding." But in a statement to Fox News Digital on Monday, Bacon said, "If PEPFAR is gutted, I am a no. But I'm told that only parts of the program will be cut. I'll need more details," The rescission package "proposes to rescind $400 million from the PEPFAR program, which is appropriated $4.4 billion annually to provide bilateral assistance to countries, many of which do not support American interests, such as South Africa," a White House official told Fox News on Monday. Read On The Fox News App House Republicans Push For Spending Cancellations As Elon Musk And Conservatives Demand Deeper Budget Cuts "The $400 million rescission eliminates wasteful programming that does not serve the American taxpayer," the official said, while maintaining that the "package does NOT rescind any life-saving assistance and in fact, continues to make available billions of resources to implement life-saving medicine, medical services, as well costs necessary to deliver these services to maintain all current individuals on treatment." Bacon was the only House Republican to vote against a measure to rename the Gulf of Mexico the Gulf of America. "I thought it was dumb. That's what people told me — they said, 'It's so dumb; just vote for it.' That argument didn't work on me," he said, according to the Times. Gop Lawmaker Blasts 'Dumb' Trump Comment On Zelenskyy Despite 'Perfect' Criticism Of Putin House leaders have pressed Bacon to keep more of his views to himself, telling him to, as the congressman put it, "quit kicking President Trump in the nuts," the outlet reported. But the lawmaker indicated that he would only press back when he believes it is needed. "You can't be anti-everything," Bacon noted, according to the outlet. "I like what the president has done on the border, so I have no problem with that." "I'd like to fight for the soul of our party," he said, according to the Times. "I don't want to be the guy who follows the flute player off the cliff. I think that's what's going on right now." Pro-ukraine Gop Rep. Bacon Declares 'Real Republicans Know That Putin's Russia Hates The West And Freedom' Bacon has served in the House of Representatives since article source: Republican rep indicates he will be 'a no' on Trump-backed rescissions measure if AIDS relief cut

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store